Free Trial
LON:MTPH

Biodexa Pharmaceuticals (MTPH) Share Price, News & Analysis

GBX 18
+17.05 (+1,794.74%)
(As of 03/27/2023)

About Biodexa Pharmaceuticals Stock (LON:MTPH)

Key Stats

Today's Range
12.50
20
50-Day Range
18
18
52-Week Range
0.90
20
Volume
73,672 shs
Average Volume
617,252 shs
Market Capitalization
£31.20 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Midatech Pharma plc, a drug delivery technology company, focuses on the research and development of medicines in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; MTD211, a long-acting formulation of brexpiprazole for the treatment of schizophrenia and adjunctive treatment of major depressive disorder; and MTD219, a long-acting formulation of tacrolimus used to lower the risk of organ transplant rejection. It also offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release drug delivery; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.

Receive MTPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biodexa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

MTPH Stock News Headlines

“A very dark day is coming to America”
Wall Street Legend on Economy: "If you knew what I know, you'd be terrified too." Something huge is headed to America's shores – and it scares the hell out of Wall St. legend Louis Navellier. When it makes landfall, its impact will be more violent and more severe than any financial crisis we've ever seen… "No matter how prepared you think you are, you aren't prepared enough," he warns.
SLRX Salarius Pharmaceuticals, Inc.
See More Headlines

MTPH Stock Analysis - Frequently Asked Questions

Biodexa Pharmaceuticals' stock was trading at GBX 18 at the beginning of the year. Since then, MTPH stock has increased by 0.0% and is now trading at GBX 18.
View the best growth stocks for 2024 here
.

Biodexa Pharmaceuticals Plc (LON:MTPH) announced its quarterly earnings results on Thursday, September, 10th. The company reported ($64.00) earnings per share for the quarter.

Shares of MTPH stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Biodexa Pharmaceuticals investors own include Aldeyra Therapeutics (ALDX), Barclays (BARC), Telefonaktiebolaget LM Ericsson (publ) (ERIC), Futura Medical (FUM), Lloyds Banking Group (LLOY), Biodexa Pharmaceuticals (MTP) and Intec Pharma (NTEC).

Company Calendar

Last Earnings
9/10/2020
Today
9/18/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
Computer Software
CIK
N/A
Fax
N/A
Employees
18
Year Founded
N/A

Profitability

Net Income
£-5,370,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£645,000.00
Cash Flow
GBX 20.53 per share
Book Value
GBX 152 per share

Miscellaneous

Free Float
N/A
Market Cap
£31.20 million
Optionable
Not Optionable
Beta
1.22
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for September 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

This page (LON:MTPH) was last updated on 9/18/2024 by MarketBeat.com Staff
From Our Partners